• Protecting Phosphorylation in Translational Research

  2026-08-23

  A thought-leadership guide linking eggshell biology, phosphatase control, and translational assay design to improve mechanistic confidence from tissue harvest through validation.

• HyperFusion high-fidelity DNA polymerase for PCR

  2026-08-22

  Learn how a proofreading DNA polymerase can strengthen C. elegans neurobiology workflows, from GC-rich genotyping panels to sequence-confirmed cloning. HyperFusion™ combines high accuracy, speed, blunt-end products, and inhibitor tolerance for demanding PCR and sequencing applications.

• LDH Cytotoxicity Assay Kit: Practical Workflow

  2026-08-21

  The LDH Cytotoxicity Assay Kit provides a non-radioactive approach to cell cytotoxicity measurement by detecting LDH released into culture medium after membrane damage. It is appropriate for comparative cell damage studies, but it should not be used as a stand-alone assay to identify apoptosis, distinguish death mechanisms, or replace interference controls and orthogonal validation.

• Oxaliplatin: DNA Damage and Cancer Research

  2026-08-20

  Oxaliplatin is a platinum-based chemotherapeutic agent that forms DNA adducts, disrupts DNA synthesis, and promotes apoptosis. Its established clinical role in metastatic colorectal cancer therapy and its use in breast-cancer research make it a useful compound for studying DNA damage, cytotoxicity, and chemotherapy resistance.

• BV6 as an IAP Antagonist for Cell-Death Mapping

  2026-08-20

  BV6 is an IAP antagonist that can reveal how cancer cells transition from survival signaling to apoptosis after chemotherapy or radiation. This article combines BV6 biology with a 2025 necroptosis study to show how pathway-resolved assays can prevent misleading cell-death conclusions.

• Tiamulin PK/PD in M. gallisepticum Infection

  2026-08-19

  The 2016 reference study established an in vivo pharmacokinetic/pharmacodynamic framework for Tiamulin treatment of experimental Mycoplasma gallisepticum infection in chickens. Its central finding was that AUC24h/MIC, rather than dose alone, correlated with bacterial reduction and provided a model-specific exposure target for regimen design.

• CCR7–Notch1 Crosstalk Promotes Mammary Cancer Stemness

  2026-08-19

  Boyle et al. identified functional crosstalk between CCR7 and Notch1 in stem-like cells from MMTV-PyMT mammary tumors. Their experiments connect chemokine-receptor signaling with Notch activation and show why simultaneous interrogation of both axes may clarify mechanisms of tumor maintenance and therapy resistance.

• MK 0893: A Translational GCGR Playbook

  2026-08-18

  MK 0893 illustrates how an allosteric glucagon receptor antagonist can connect receptor pharmacology, cAMP biology, animal-model efficacy, and translational decision-making in type 2 diabetes research.

• CCK-8 in Osteoblast Research: Reading Beyond OD

  2026-08-18

  Discover how cck8 supports cell proliferation, viability, and cytotoxicity analysis in osteoblast models. This article explains how to interpret WST-8 signals alongside the Prmt1–Ddx17–Sh2b1 mechanism rather than treating absorbance as a standalone cell count.

• TBST (Tris-Buffered Saline and Tween 20) Guide

  2026-08-17

  TBST is a ready-to-use isotonic buffered salt solution with Tween 20 for reducing nonspecific binding during antibody-based assays. It is suitable for validated Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry workflows, but should not be treated as a universal cell-culture, injection, or assay-independent buffer.

• Gamma-Linolenic Acid: From Signal to Study Design

  2026-08-17

  Gamma-linolenic acid research is most informative when receptor signaling, lipid context, and cytotoxicity are interpreted together. This article connects GLA mechanism with the latest arachidonic acid immunity findings and provides a decision framework for anti-inflammatory research, apoptosis assays, and translational models.

• Imipramine: Causal Assay Design for Autophagy

  2026-08-16

  Imipramine can support more rigorous autophagy, apoptosis, and lipid-signaling experiments when used within a causal assay framework. This guide connects its research profile to ceramide-centered lipidomics while distinguishing established evidence from testable hypotheses.

• Rocket-Like Nanomedicine Reprograms PDAC Stroma

  2026-08-15

  Fu and colleagues developed an acid-responsive, sequential-release nanomedicine that remodels pancreatic ductal adenocarcinoma stroma before delivering gemcitabine more deeply. In a PDAC mouse model, the Si-G@Ca-H/uPA platform produced marked tumor regression without reported overt side effects, supporting stromal reprogramming as an alternative to wholesale stromal depletion.

• Plk1 Control of p31comet in Checkpoint Disassembly

  2026-08-15

  The reference study identifies Polo-like kinase 1 (Plk1) as a direct regulator of p31comet, the Mad2-binding factor that helps TRIP13 disassemble mitotic checkpoint complexes. Its central finding is that Plk1 phosphorylation of p31comet at S102 suppresses checkpoint-complex disassembly, providing a mechanism that may prevent premature cycling between checkpoint assembly and disassembly.

• Promethazine HCl in Macrophage Assays

  2026-08-14

  Build a reproducible macrophage workflow that separates histamine H1 receptor effects from ROS- and autophagy-dependent host defense. This guide turns Promethazine HCl into a practical probe for inflammation research, intracellular bacterial assays, and follow-up signaling studies.

450 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page